International Normalized Ratio Relevance to the Observed Coagulation Abnormalities in Warfarin Treatment and Disseminated Intravascular Coagulation

The development of coagulation abnormalities is common in patients with sepsis. Sepsis-associated coagulopathy (SAC) is typically diagnosed by prothrombin time (PT) prolongation or elevated international normalized ratio (INR) in conjunction with reduced platelet count. INR is also used to monitor w...

Full description

Saved in:

Bibliographic Details
Published in:	Clinical and applied thrombosis/hemostasis Vol. 24; no. 7; pp. 1033 - 1041
Main Authors:	Walborn, Amanda, Williams, Mark, Fareed, Jawed, Hoppensteadt, Debra
Format:	Journal Article
Language:	English
Published:	Los Angeles, CA SAGE Publications 01.10.2018 SAGE PUBLICATIONS, INC
Subjects:	Anticoagulants Disseminated Intravascular Coagulation - drug therapy Female Humans International Normalized Ratio Male Original Patients Sepsis Sepsis - drug therapy Warfarin - pharmacology Warfarin - therapeutic use blood coagulation factors INR disseminated intravascular coagulation warfarin
ISSN:	1076-0296, 1938-2723, 1938-2723
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	The development of coagulation abnormalities is common in patients with sepsis. Sepsis-associated coagulopathy (SAC) is typically diagnosed by prothrombin time (PT) prolongation or elevated international normalized ratio (INR) in conjunction with reduced platelet count. INR is also used to monitor warfarin-treated patients. However, due to the different natures of SAC and warfarin anticoagulation, it is likely that the same INR value provides different information in these two patient populations. The purpose of this study was to compare measures of coagulation function and clotting factor levels in patients with SAC to those observed in patients receiving warfarin anticoagulation. Deidentified plasma samples were collected at baseline from patients diagnosed with SAC and from patients receiving warfarin. These plasma samples were evaluated for PT/INR, activated partial thromboplastin time (aPTT), fibrinogen, and functional and immunologic levels of factors VII, IX, and X. Both aPTT and fibrinogen correlated with INR in patients with SAC, but not in patients treated with warfarin. Factors VII, IX, and X showed an inverse relationship with INR in the anticoagulated patients; however, no relationship between factor level and INR was observed in patients with SAC. Distinct patterns of coagulopathy were observed in patients with SAC and patients receiving warfarin anticoagulation, and equivalent INR values were associated with distinct coagulation profiles in the two patient groups. These results suggest that an abnormal INR provides different information about the coagulation status in patients with disseminated intravascular coagulation than in patients receiving warfarin. This may indicate that an equivalently increased INR predicts different bleeding risks in these two patient groups.
AbstractList	The development of coagulation abnormalities is common in patients with sepsis. Sepsis-associated coagulopathy (SAC) is typically diagnosed by prothrombin time (PT) prolongation or elevated international normalized ratio (INR) in conjunction with reduced platelet count. INR is also used to monitor warfarin-treated patients. However, due to the different natures of SAC and warfarin anticoagulation, it is likely that the same INR value provides different information in these two patient populations. The purpose of this study was to compare measures of coagulation function and clotting factor levels in patients with SAC to those observed in patients receiving warfarin anticoagulation. Deidentified plasma samples were collected at baseline from patients diagnosed with SAC and from patients receiving warfarin. These plasma samples were evaluated for PT/INR, activated partial thromboplastin time (aPTT), fibrinogen, and functional and immunologic levels of factors VII, IX, and X. Both aPTT and fibrinogen correlated with INR in patients with SAC, but not in patients treated with warfarin. Factors VII, IX, and X showed an inverse relationship with INR in the anticoagulated patients; however, no relationship between factor level and INR was observed in patients with SAC. Distinct patterns of coagulopathy were observed in patients with SAC and patients receiving warfarin anticoagulation, and equivalent INR values were associated with distinct coagulation profiles in the two patient groups. These results suggest that an abnormal INR provides different information about the coagulation status in patients with disseminated intravascular coagulation than in patients receiving warfarin. This may indicate that an equivalently increased INR predicts different bleeding risks in these two patient groups.The development of coagulation abnormalities is common in patients with sepsis. Sepsis-associated coagulopathy (SAC) is typically diagnosed by prothrombin time (PT) prolongation or elevated international normalized ratio (INR) in conjunction with reduced platelet count. INR is also used to monitor warfarin-treated patients. However, due to the different natures of SAC and warfarin anticoagulation, it is likely that the same INR value provides different information in these two patient populations. The purpose of this study was to compare measures of coagulation function and clotting factor levels in patients with SAC to those observed in patients receiving warfarin anticoagulation. Deidentified plasma samples were collected at baseline from patients diagnosed with SAC and from patients receiving warfarin. These plasma samples were evaluated for PT/INR, activated partial thromboplastin time (aPTT), fibrinogen, and functional and immunologic levels of factors VII, IX, and X. Both aPTT and fibrinogen correlated with INR in patients with SAC, but not in patients treated with warfarin. Factors VII, IX, and X showed an inverse relationship with INR in the anticoagulated patients; however, no relationship between factor level and INR was observed in patients with SAC. Distinct patterns of coagulopathy were observed in patients with SAC and patients receiving warfarin anticoagulation, and equivalent INR values were associated with distinct coagulation profiles in the two patient groups. These results suggest that an abnormal INR provides different information about the coagulation status in patients with disseminated intravascular coagulation than in patients receiving warfarin. This may indicate that an equivalently increased INR predicts different bleeding risks in these two patient groups. The development of coagulation abnormalities is common in patients with sepsis. Sepsis-associated coagulopathy (SAC) is typically diagnosed by prothrombin time (PT) prolongation or elevated international normalized ratio (INR) in conjunction with reduced platelet count. INR is also used to monitor warfarin-treated patients. However, due to the different natures of SAC and warfarin anticoagulation, it is likely that the same INR value provides different information in these two patient populations. The purpose of this study was to compare measures of coagulation function and clotting factor levels in patients with SAC to those observed in patients receiving warfarin anticoagulation. Deidentified plasma samples were collected at baseline from patients diagnosed with SAC and from patients receiving warfarin. These plasma samples were evaluated for PT/INR, activated partial thromboplastin time (aPTT), fibrinogen, and functional and immunologic levels of factors VII, IX, and X. Both aPTT and fibrinogen correlated with INR in patients with SAC, but not in patients treated with warfarin. Factors VII, IX, and X showed an inverse relationship with INR in the anticoagulated patients; however, no relationship between factor level and INR was observed in patients with SAC. Distinct patterns of coagulopathy were observed in patients with SAC and patients receiving warfarin anticoagulation, and equivalent INR values were associated with distinct coagulation profiles in the two patient groups. These results suggest that an abnormal INR provides different information about the coagulation status in patients with disseminated intravascular coagulation than in patients receiving warfarin. This may indicate that an equivalently increased INR predicts different bleeding risks in these two patient groups.
Author	Williams, Mark Walborn, Amanda Fareed, Jawed Hoppensteadt, Debra
AuthorAffiliation	1 Department of Pathology, Loyola University Medical Center, Maywood, IL, USA 3 Division of Pulmonary and Critical Care Medicine, Indiana University School of Medicine, Indianapolis, IN, USA 2 Department of Pharmacology, Loyola University Medical Center, Maywood, IL, USA
AuthorAffiliation_xml	– name: 1 Department of Pathology, Loyola University Medical Center, Maywood, IL, USA – name: 3 Division of Pulmonary and Critical Care Medicine, Indiana University School of Medicine, Indianapolis, IN, USA – name: 2 Department of Pharmacology, Loyola University Medical Center, Maywood, IL, USA
Author_xml	– sequence: 1 givenname: Amanda surname: Walborn fullname: Walborn, Amanda – sequence: 2 givenname: Mark surname: Williams fullname: Williams, Mark – sequence: 3 givenname: Jawed surname: Fareed fullname: Fareed, Jawed – sequence: 4 givenname: Debra surname: Hoppensteadt fullname: Hoppensteadt, Debra
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/29848060$$D View this record in MEDLINE/PubMed
BookMark	eNp9Us1vFCEUJ6bGfujdkyHx4mUUGBZ2LibNWrVJY5OmxuPkDfNmS8NABWYT_Tf6D8t0a62b6IkHv4_348Eh2fPBIyEvOXvLudbvONOKiUbxpdaiXtRPyAFv6mUlym6v1AWuZnyfHKZ0zRhvVKOekX3RLOWSKXZAbk99xugh2-DB0S8hjuDsT-zpxXxGL9DhBrxBmgPNV0jPu4RxU_BVgPXk7oT0uPNbYbaYqPX0G8QBYikuI0Ie0WcKvqcfbEo42tKuGJTOETaQTHGJj-2ek6cDuIQv7tcj8vXjyeXqc3V2_ul0dXxWGalErrpBdUPfGAZDr3QHQ62BdVyC6JkwkptFL6Fm2AnJBjBSa7lgQy0Y070UDauPyPut783UjdgbnAO59ibaEeKPNoBt_0a8vWrXYdMqzWUxKwZv7g1i-D5hyu1ok0HnwGOYUiuY1I1gaqEK9fUO9TpMZe6usGpea75sxGz46nGihyi_36sQ2JZgYkgp4vBA4aydv0S7-yWKRO1IjM13cy53su5_wmorTLDGP3H_yf8FKzbKAQ
CitedBy_id	crossref_primary_10_1371_journal_pdig_0000130 crossref_primary_10_3171_CASE21506 crossref_primary_10_12998_wjcc_v8_i19_4370 crossref_primary_10_1371_journal_pone_0251248 crossref_primary_10_1371_journal_pone_0318365 crossref_primary_10_1016_j_jtha_2024_05_013 crossref_primary_10_3390_jcm10122693 crossref_primary_10_1186_s12877_022_02899_7
Cites_doi	10.1016/S0140-6736(04)17667-8 10.1001/archinte.164.19.2176 10.1186/cc2459 10.1097/MBC.0b013e3283367882 10.1097/01.CCM.0000295317.97245.2D 10.1097/00000658-199101000-00014 10.1016/j.jacc.2012.04.063 10.1038/nrdp.2016.37 10.1002/ajh.20597 10.1111/jth.13061 10.1097/01.CCM.0000153520.31562.48 10.1097/CCM.0b013e3181eb9d2b 10.1097/CCM.0b013e31827c09f8 10.1001/jama.290.2.238 10.1073/pnas.83.12.4533 10.1097/MBC.0000000000000351 10.1016/j.jiac.2013.07.006 10.1097/01.TA.0000075338.21177.EF 10.1097/01.CCM.0000147769.07699.E3 10.1073/pnas.0504526102 10.1165/ajrcmb.22.4.f184 10.1056/NEJM199908193410807 10.1111/j.1365-2141.2006.06281.x 10.1186/cc13190 10.1097/CCM.0b013e31828e9b03 10.1586/eri.12.50 10.1186/cc7765 10.1073/pnas.83.10.3460 10.1111/j.1538-7836.2011.04323.x 10.1006/cyto.1996.0110 10.1016/j.thromres.2004.06.028 10.1161/01.CIR.0000131660.51520.9A 10.1055/s-0037-1616068
ContentType	Journal Article
Copyright	The Author(s) 2018 The Author(s) 2018. This work is licensed under the Creative Commons Attribution – Non-Commercial License http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2018 2018 SAGE Publications Inc. unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses
Copyright_xml	– notice: The Author(s) 2018 – notice: The Author(s) 2018. This work is licensed under the Creative Commons Attribution – Non-Commercial License http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2018 2018 SAGE Publications Inc. unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses
DBID	AFRWT AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM
DOI	10.1177/1076029618772353
DatabaseName	Sage Journals GOLD Open Access 2024 CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles)
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest One Health & Nursing ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic Publicly Available Content Database MEDLINE CrossRef
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: PIMPY name: ProQuest Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine Anatomy & Physiology
EISSN	1938-2723
EndPage	1041
ExternalDocumentID	PMC6714745 29848060 10_1177_1076029618772353 10.1177_1076029618772353
Genre	Journal Article
GrantInformation_xml	– fundername: Achievement Rewards for College Scientists Foundation funderid: https://doi.org/10.13039/100008227 – fundername: ;
GroupedDBID	--- -TM .2F .2G 01A 0R~ 29B 31S 31Y 36B 4.4 53G 54M 5GY 5VS 7X7 8FI 8FJ AABMB AACKU AADUE AAGGD AAJIQ AAJOX AAJPV AANSI AAPEO AAQDB AAQGT AAQXH AARDL AARIX AASGM AAXOT AAYTG AAZBJ ABAWP ABDWY ABEIX ABFWQ ABHKI ABJIS ABKRH ABPGX ABQKF ABQXT ABRHV ABUWG ABVFX ABVVC ABXGC ABYTW ACARO ACDSZ ACDXX ACFMA ACFYK ACGBL ACGFS ACLHI ACOFE ACROE ACRPL ADBBV ADEBD ADEIA ADMPF ADNBR ADNMO ADOGD ADSTG ADTBJ ADUKL ADYCS ADZZY AECVZ AENEX AEQLS AERKM AEUHG AEWDL AEXFG AEXNY AFCOW AFEET AFKBI AFKRA AFKRG AFRWT AFUIA AFWMB AGNHF AGQPQ AHHFK AIGRN AJABX AJEFB AJMMQ AJSCY AJUZI ALIPV ALMA_UNASSIGNED_HOLDINGS ARTOV ASPBG AUTPY AVWKF AYAKG AZFZN B8M B8O B93 BDDNI BENPR BKSCU BPHCQ BSEHC BVXVI CAG CBRKF CCPQU CDWPY CFDXU COF CORYS CQQTX CS3 CUTAK DC- DC. DC0 DD- DD0 DE- DOPDO DU5 D~Y EBS EJD EMB EMOBN F5P FEDTE FYUFA GROUPED_DOAJ GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION H13 HF~ HMCUK HVGLF HYE HZ~ J8X K.F K.J N9A O9- OK1 OVD P.B PHGZM PHGZT PIMPY PQQKQ Q1R Q7K Q7R Q7X Q82 RIG ROL RPM S01 SAUOL SCDPB SCNPE SFB SFC SFN SGA SGP SGX SQCSI SV3 TEORI UKHRP ZONMY ZPPRI ZRKOI ZSSAH AAEJI AAYXX ACHEB AFFHD CITATION CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 PUEGO 5PM
ID	FETCH-LOGICAL-c462t-bf6bfd9c0afd67baf37a0b14a2d02c41c5d4a30eb240fac477450f32007d42903
IEDL.DBID	7X7
ISICitedReferencesCount	9
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000443730600005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1076-0296 1938-2723
IngestDate	Tue Nov 04 01:58:33 EST 2025 Thu Sep 04 17:40:16 EDT 2025 Tue Oct 07 07:03:15 EDT 2025 Mon Jul 21 05:56:03 EDT 2025 Sat Nov 29 08:13:38 EST 2025 Tue Nov 18 21:33:19 EST 2025 Tue Jun 17 22:47:09 EDT 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	7
Keywords	blood coagulation factors INR disseminated intravascular coagulation warfarin
Language	English
License	This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c462t-bf6bfd9c0afd67baf37a0b14a2d02c41c5d4a30eb240fac477450f32007d42903
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
OpenAccessLink	https://www.proquest.com/docview/2313718925?pq-origsite=%requestingapplication%
PMID	29848060
PQID	2313718925
PQPubID	4450586
PageCount	9
ParticipantIDs	pubmedcentral_primary_oai_pubmedcentral_nih_gov_6714745 proquest_miscellaneous_2047920656 proquest_journals_2313718925 pubmed_primary_29848060 crossref_primary_10_1177_1076029618772353 crossref_citationtrail_10_1177_1076029618772353 sage_journals_10_1177_1076029618772353
PublicationCentury	2000
PublicationDate	2018-10-01
PublicationDateYYYYMMDD	2018-10-01
PublicationDate_xml	– month: 10 year: 2018 text: 2018-10-01 day: 01
PublicationDecade	2010
PublicationPlace	Los Angeles, CA
PublicationPlace_xml	– name: Los Angeles, CA – name: United States – name: Thousand Oaks – name: Sage CA: Los Angeles, CA
PublicationTitle	Clinical and applied thrombosis/hemostasis
PublicationTitleAlternate	Clin Appl Thromb Hemost
PublicationYear	2018
Publisher	SAGE Publications SAGE PUBLICATIONS, INC
Publisher_xml	– name: SAGE Publications – name: SAGE PUBLICATIONS, INC
References	Ogura, Gando, Saitoh 2014; 20 Martin 2012; 10 Gando, Saitoh, Ogura 2008; 36 Hezi-Yamit, Wong, Bien-Ly 2005; 102 Vincent, Ramesh, Ernest 2013; 41 Cauchie, Cauchie, Zouaoui Boudjeltia 2006; 81 Bakhtiari, Meijers, de Jonge 2004; 32 Dhainaut, Shorr, Macias 2005; 33 Koami, Sakamoto, Ohta 2015; 26 Guo, Lip, Apstolakis 2012; 60 Bevilacqua, Pober, Majeau 1986; 83 Abraham, Reinhart, Opal 2003; 290 Levi, van der Poll, Buller 2004; 109 Osnes, Westvik, Joo 1996; 8 Abraham 2000; 22 Koyama, Madiowa, Nunomiya 2014; 18 Hawiger, Veach, Zienkiewicz 2015; 13 Esmon 2004; 114 Nawroth, Handley, Esmon 1986; 83 MacLeod, Lynn, McKenney 2003; 55 Murphy, Xu, Kochanek 2013; 61 Kucher, Connolly, Beckman 2004; 164 Walsh, Stanwoth, Prescott 2010; 38 Esmon, Xu, Lupu 2011; 9 Taylor, Toh, Hoots, Wada, Levi 2001; 86 Gando, Levi, Toh 2016; 2 Tanaka, Sugimoto, Yoshioka 1991; 213 Johansson, Stensballe, Vindelov 2010; 21 Gaieski, Edwards, Kallan 2013; 41 Levi, Ten Cate 1999; 341 Daudel, Kessler, Folly 2009; 13 Annane, Bellissant, Cavaillon 2005; 365 Collins, Macchiavello, Lewis 2006; 135 Kinasewitz, Yan, Basson 2004; 8 bibr12-1076029618772353 bibr17-1076029618772353 bibr20-1076029618772353 bibr33-1076029618772353 bibr34-1076029618772353 bibr9-1076029618772353 bibr21-1076029618772353 bibr3-1076029618772353 bibr25-1076029618772353 bibr30-1076029618772353 bibr18-1076029618772353 bibr4-1076029618772353 bibr22-1076029618772353 bibr8-1076029618772353 bibr13-1076029618772353 bibr26-1076029618772353 bibr31-1076029618772353 bibr19-1076029618772353 Murphy SL (bibr1-1076029618772353) 2013; 61 bibr27-1076029618772353 bibr14-1076029618772353 bibr23-1076029618772353 bibr5-1076029618772353 bibr10-1076029618772353 bibr7-1076029618772353 bibr24-1076029618772353 bibr29-1076029618772353 bibr16-1076029618772353 bibr32-1076029618772353 bibr15-1076029618772353 bibr2-1076029618772353 bibr28-1076029618772353 bibr6-1076029618772353 bibr11-1076029618772353
References_xml	– volume: 32 start-page: 2416 issue: 12 year: 2004 end-page: 2421 article-title: Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation publication-title: Crit Care Med – volume: 10 start-page: 701 issue: 6 year: 2012 end-page: 706 article-title: Sepsis, severe sepsis, and septic shock: changes in incidence, pathogens and outcomes publication-title: Expert Rev Anti Infect Ther – volume: 61 start-page: 1 issue: 4 year: 2013 end-page: 117 article-title: Deaths: final data for 2010 publication-title: Nat Vital Stat Rep – volume: 22 start-page: 401 issue: 4 year: 2000 end-page: 404 article-title: Coagulation abnormalities in acute lung injury and sepsis publication-title: Am J Respir Cell Mol Biol – volume: 18 start-page: 813 issue: 1 year: 2014 end-page: 824 article-title: Combination of thrombin–antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study publication-title: Crit Care – volume: 83 start-page: 3460 issue: 10 year: 1986 end-page: 3464 article-title: Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity publication-title: Proc Natl Acad Sci U S A – volume: 213 start-page: 81 issue: 1 year: 1991 end-page: 85 article-title: Role of granulocyte elastase in tissue injury in patients with septic shock complicated by multiple-organ failure publication-title: Ann Surg – volume: 114 start-page: 321 issue: 5-6 year: 2004 end-page: 327 article-title: The impact of the inflammatory response on coagulation publication-title: Thromb Res – volume: 33 start-page: 341 issue: 2 year: 2005 end-page: 348 article-title: Dynamic evolution of coagulopathy on the first day of severe sepsis: relationship with mortality and organ failure publication-title: Crit Care Med – volume: 41 start-page: 2070 issue: 9 year: 2013 end-page: 2079 article-title: A randomized, double-blind, placebo-controlled phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation publication-title: Crit Care Med – volume: 109 start-page: 2698 issue: 22 year: 2004 end-page: 2704 article-title: Bidirectional relation between inflammation and coagulation publication-title: Circulation – volume: 8 start-page: R82 issue: 2 year: 2004 end-page: R90 article-title: Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism publication-title: Crit Care – volume: 365 start-page: 63 issue: 9453 year: 2005 end-page: 78 article-title: Septic shock publication-title: Lancet – volume: 2 start-page: 1 year: 2016 end-page: 16 article-title: Disseminated intravascular coagulation publication-title: Nat Rev Dis Primers – volume: 86 start-page: 1327 issue: 5 year: 2001 end-page: 1330 article-title: Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation publication-title: Thromb Haemost – volume: 41 start-page: 1167 issue: 5 year: 2013 end-page: 1174 article-title: Benchmarking the incidence and mortality of severe sepsis in the United States publication-title: Crit Care Med – volume: 341 start-page: 586 issue: 8 year: 1999 end-page: 592 article-title: Disseminated intravascular coagulation publication-title: N Engl J Med – volume: 8 start-page: 822 issue: 11 year: 1996 end-page: 827 article-title: Inhibition of IL-1 induced tissue factor (TF) synthesis and procoagulant activity (PCA) in purified human monocytes by IL-4, IL-10 and IL-13 publication-title: Cytokine – volume: 81 start-page: 414 issue: 6 year: 2006 end-page: 419 article-title: Diagnosis and prognosis of overt disseminated intravascular coagulation in a general hospital—meaning of the ISTH score system, fibrin monomers, and lipoprotein–C-reactive protein complex formation publication-title: Am J Hematol – volume: 55 start-page: 39 issue: 1 year: 2003 end-page: 44 article-title: Early coagulopathy predicts mortality in trauma publication-title: J Trauma – volume: 164 start-page: 2176 issue: 19 year: 2004 end-page: 2179 article-title: International normalized ration increase before warfarin-associated hemorrhage publication-title: Arch Intern Med – volume: 20 start-page: 157 issue: 3 year: 2014 end-page: 162 article-title: Epidemiology of severe sepsis in Japanese intensive care units: a prospective multicenter study publication-title: J Infect Chemother – volume: 135 start-page: 220 issue: 2 year: 2006 end-page: 227 article-title: Global tests of haemostasis in critically ill patients with severe sepsis syndrome compared to controls publication-title: Br J Haematol – volume: 83 start-page: 4533 issue: 12 year: 1986 end-page: 4537 article-title: Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1 publication-title: Proc Natl Acad Sci U S A – volume: 36 start-page: 145 issue: 1 year: 2008 end-page: 151 article-title: Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: results of a multicenter, prospective survey publication-title: Crit Care Med – volume: 102 start-page: 12077 issue: 34 year: 2005 end-page: 12082 article-title: Synergistic induction of tissue factor by coagulation factor Xa and TNF: evidence for involvement of negative regulatory signaling cascades publication-title: Proc Natl Acad Sci U S A – volume: 60 start-page: 2263 issue: 22 year: 2012 end-page: 2270 article-title: Inflammation in atrial fibrillation publication-title: J Am Coll Cardiol – volume: 26 start-page: 778 issue: 7 year: 2015 end-page: 783 article-title: Can rotational thromboelastometry predict septic disseminated intravascular coagulation? publication-title: Blood Coagul Fibrinolysis – volume: 21 start-page: 168 issue: 2 year: 2010 end-page: 174 article-title: Hypocoagulability, as elevated by thromboelastography, at admission to the ICU is associated with increased 30-day mortality publication-title: Blood Coagul Fibrinol – volume: 13 start-page: R42 issue: 2 year: 2009 article-title: Thromboelastometry for the assessment of coagulation abnormalities in early and established adult sepsis: a prospective cohort study publication-title: Crit Care – volume: 290 start-page: 238 issue: 2 year: 2003 end-page: 247 article-title: Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis publication-title: J Am Med Assoc – volume: 13 start-page: 1743 issue: 10 year: 2015 end-page: 1756 article-title: New paradigms in sepsis: from prevention to protection of failing microcirculation publication-title: J Thromb Haemost – volume: 38 start-page: 1939 issue: 10 year: 2010 end-page: 1946 article-title: Prevalence, management, and outcomes of critically ill patients with prothrombin time prolongation in United Kingdom intensive care units publication-title: Crit Care Med – volume: 9 start-page: 182 issue: suppl 1 year: 2011 end-page: 188 article-title: Innate immunity and coagulation publication-title: J Thromb Haemost – ident: bibr6-1076029618772353 doi: 10.1016/S0140-6736(04)17667-8 – ident: bibr34-1076029618772353 doi: 10.1001/archinte.164.19.2176 – ident: bibr25-1076029618772353 doi: 10.1186/cc2459 – ident: bibr33-1076029618772353 doi: 10.1097/MBC.0b013e3283367882 – ident: bibr21-1076029618772353 doi: 10.1097/01.CCM.0000295317.97245.2D – ident: bibr5-1076029618772353 doi: 10.1097/00000658-199101000-00014 – ident: bibr7-1076029618772353 doi: 10.1016/j.jacc.2012.04.063 – ident: bibr16-1076029618772353 doi: 10.1038/nrdp.2016.37 – ident: bibr20-1076029618772353 doi: 10.1002/ajh.20597 – ident: bibr3-1076029618772353 doi: 10.1111/jth.13061 – ident: bibr27-1076029618772353 doi: 10.1097/01.CCM.0000153520.31562.48 – ident: bibr29-1076029618772353 doi: 10.1097/CCM.0b013e3181eb9d2b – ident: bibr2-1076029618772353 doi: 10.1097/CCM.0b013e31827c09f8 – ident: bibr30-1076029618772353 doi: 10.1001/jama.290.2.238 – ident: bibr13-1076029618772353 doi: 10.1073/pnas.83.12.4533 – ident: bibr26-1076029618772353 doi: 10.1097/MBC.0000000000000351 – ident: bibr22-1076029618772353 doi: 10.1016/j.jiac.2013.07.006 – ident: bibr28-1076029618772353 doi: 10.1097/01.TA.0000075338.21177.EF – ident: bibr17-1076029618772353 doi: 10.1097/01.CCM.0000147769.07699.E3 – ident: bibr14-1076029618772353 doi: 10.1073/pnas.0504526102 – volume: 61 start-page: 1 issue: 4 year: 2013 ident: bibr1-1076029618772353 publication-title: Nat Vital Stat Rep – ident: bibr11-1076029618772353 doi: 10.1165/ajrcmb.22.4.f184 – ident: bibr18-1076029618772353 doi: 10.1056/NEJM199908193410807 – ident: bibr24-1076029618772353 doi: 10.1111/j.1365-2141.2006.06281.x – ident: bibr19-1076029618772353 doi: 10.1186/cc13190 – ident: bibr31-1076029618772353 doi: 10.1097/CCM.0b013e31828e9b03 – ident: bibr4-1076029618772353 doi: 10.1586/eri.12.50 – ident: bibr32-1076029618772353 doi: 10.1186/cc7765 – ident: bibr9-1076029618772353 doi: 10.1073/pnas.83.10.3460 – ident: bibr15-1076029618772353 doi: 10.1111/j.1538-7836.2011.04323.x – ident: bibr10-1076029618772353 doi: 10.1006/cyto.1996.0110 – ident: bibr8-1076029618772353 doi: 10.1016/j.thromres.2004.06.028 – ident: bibr12-1076029618772353 doi: 10.1161/01.CIR.0000131660.51520.9A – ident: bibr23-1076029618772353 doi: 10.1055/s-0037-1616068
SSID	ssj0019696
Score	2.2334607
Snippet	The development of coagulation abnormalities is common in patients with sepsis. Sepsis-associated coagulopathy (SAC) is typically diagnosed by prothrombin time...
SourceID	pubmedcentral proquest pubmed crossref sage
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	1033
SubjectTerms	Anticoagulants Disseminated Intravascular Coagulation - drug therapy Female Humans International Normalized Ratio Male Original Patients Sepsis Sepsis - drug therapy Warfarin - pharmacology Warfarin - therapeutic use
Title	International Normalized Ratio Relevance to the Observed Coagulation Abnormalities in Warfarin Treatment and Disseminated Intravascular Coagulation
URI	https://journals.sagepub.com/doi/full/10.1177/1076029618772353 https://www.ncbi.nlm.nih.gov/pubmed/29848060 https://www.proquest.com/docview/2313718925 https://www.proquest.com/docview/2047920656 https://pubmed.ncbi.nlm.nih.gov/PMC6714745
Volume	24
WOSCitedRecordID	wos000443730600005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1938-2723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0019696 issn: 1076-0296 databaseCode: 7X7 dateStart: 19950101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1938-2723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0019696 issn: 1076-0296 databaseCode: BENPR dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Publicly Available Content Database customDbUrl: eissn: 1938-2723 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0019696 issn: 1076-0296 databaseCode: PIMPY dateStart: 19950101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LbxMxEB5BixCXAi2FhVIZCVXisIrX9r5OKJRW9NAQRUWEUzRr70Kk4m2TFAn-Bn8Yz66zTajohUsi-ZH12mN7Hl--AXhdqMyIUjrbpNQmVInKQ0RNQd6o4rHRQpTYJJtIB4NsPM6H3uE297DK5ZnYHNSm1uQj7zk9RLpzNBfx24vLkLJGUXTVp9C4C5uUNpvkPB13BlfD_NJiDglom6-EKXtURkWuVypkLNevpRu65k3I5Aruq7mKjh_-70s8gi2vhLJ-KzWP4U5pt2Gnb50B_v0nO2ANLLTxt2_D_VMffd-B32vuQzYgdfd8-qs0bERlbET_VScpYouaOcWSfSzI5-vqD2v86vOEsX5h245E5cqmln3GWeUsdsvOlqB3htaw94QUIKCO04nZCc3HEjW7-nNP4NPx0dnhh9AndQi1SsQiLKqkqEyuOVYmSQusZIq8iBQKw4VWkY6NQsmdwa94hVo59TTmlSSXqnF3J5e7sGFrWz4DJiViqpSSSBRBSmOmFepSSB3FKCoRQG-5phPtGc8p8cb5JPIk539LQQBvuh4XLdvHLW33lms88ft-Prle4ABeddVux1IYBm1ZX7k2xOovnOqXBPC0laruYSLPVMYTHkC6Jm9dA2IDX6-x028NK3iSRsrNVQAHJJnXQ_rX-J_fPv4X8MDphi31b7QHG4vZVfkS7ukfi-l8tt_ss-Yz24fNd0eD4ch9D09Oh1_-AGJRM5A
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VgoALj5ZHoICRoBKHaB3beR0QWrVUXbVdULWIvYWJncBKJSm7W1D5G_wPfiOevLpLRW89cItsJ7Gcmck3ns8zAC9SFRmRSeubZNq4KlCxi6gpyOvl3DdaiAyrYhPhcBiNx_H7FfjdnoUhWmVrEytDbUpNe-Q9i0OktaOx8N8cf3OpahRFV9sSGrVY7GWnP6zLNns92Lbf96UQO29HW7tuU1XA1SoQczfNgzQ3seaYmyBMMZch8tRTKAwXWnnaNwoltx6n4jlqZfGRz3NJe3rGGm8u7XOvwFV7GZKzF447B6_KNFNzHInYGy-ERXvURk1eZOGs9OXyb_Actj1P0VzgmVW_vp3b_9ui3YFbDchm_Vor7sJKVqzBer_Aefn1lG2yivZaxRPW4PpBwy5Yh19L26NsSHD-aPIzM-yQ2tghncUnLWHzklngzN6ltKdt-7dK_NzUQWP9tKhvpFS1bFKwjzjNcWovRi2pn2Fh2DYxIYiIZDE_G9D6t6zgxcfdgw-XslL3YbUoi-whMCkRQ6WUREqBpDRGWqHOhNSejyIXDvRaGUp0k9GdCoscJV6TxP1vqXPgVXfHcZ3N5IKxG61MJY1dmyVnAuXA867bWiQKM2GRlSd2DFUtEBbaBg48qKW4e5mIIxXxgDsQLsl3N4CynS_3FJMvVdbzIPSUXSsHNkkTzqb0r_k_unj-z-DG7uhgP9kfDPcew02Lg-s0x94GrM6nJ9kTuKa_zyez6dNKxxl8umz9-ANU240e
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=International+Normalized+Ratio+Relevance+to+the+Observed+Coagulation+Abnormalities+in+Warfarin+Treatment+and+Disseminated+Intravascular+Coagulation&rft.jtitle=Clinical+and+applied+thrombosis%2Fhemostasis&rft.au=Walborn%2C+Amanda&rft.au=Williams%2C+Mark&rft.au=Fareed%2C+Jawed&rft.au=Hoppensteadt%2C+Debra&rft.date=2018-10-01&rft.pub=SAGE+Publications&rft.issn=1076-0296&rft.eissn=1938-2723&rft.volume=24&rft.issue=7&rft.spage=1033&rft.epage=1041&rft_id=info:doi/10.1177%2F1076029618772353&rft_id=info%3Apmid%2F29848060&rft.externalDocID=PMC6714745
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1076-0296&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1076-0296&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1076-0296&client=summon